Meloxicam Ciclum (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the synthesis of prostaglandins—key compounds that cause inflammation, pain, and fever. At higher doses it may also affect COX‑1, contributing to its overall anti‑inflammatory effect.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, age, renal function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Meloxicam is classified as Pregnancy Category C, meaning risk cannot be ruled out and it should be avoided, especially in the third trimester. Limited data are available for breastfeeding; therefore, use only if the potential benefit justifies the potential risk to the infant.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam has a longer half‑life than ibuprofen, allowing once‑daily dosing for many patients. It is more selective for COX‑2 at standard doses, which may reduce gastrointestinal irritation compared with non‑selective NSAIDs, though the overall safety profile remains similar.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect from moisture and light. Do not store in a refrigerator or freezer, and keep out of reach of children.

Meloxicam Ciclum is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce possible stomach upset. Follow the prescriber’s dosing schedule precisely.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, and acute kidney injury. Patients should seek immediate medical attention if they notice signs such as black stools, chest pain, rash, or sudden swelling.

Meloxicam should be avoided by individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal impairment. It is also contraindicated in the third trimester of pregnancy.